2-(3-Bromoimidazo[1,2-a]pyrimidin-7-yl)propan-2-ol → HCID 69709152, compound

HRID 2184054Notes

Reaction equation

HRID 2184054 reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5](B(O)O)=[CH:4][C:3]=1[C:11]1[N:12]=[N:13][CH:14]=[CH:15][CH:16]=1.Br[C:18]1[N:22]2[CH:23]=[CH:24][C:25]([C:27]([OH:30])([CH3:29])[CH3:28])=[N:26][C:21]2=[N:20][CH:19]=1>>[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:18]2[N:22]3[CH:23]=[CH:24][C:25]([C:27]([OH:30])([CH3:28])[CH3:29])=[N:26][C:21]3=[N:20][CH:19]=2)=[CH:4][C:3]=1[C:11]1[N:12]=[N:13][CH:14]=[CH:15][CH:16]=1

Participants

3

Procedure

4-Fluoro-3-(pyridazin-3-yl)phenylboronic acid (80 mg, 0.37 mmol) was coupled to 2-(3-bromoimidazo[1,2-α]pyrimidin-7-yl)propan-2-ol (94 mg, 0.37 mmol) using the method in Example 1. Purification by chromatography on silica gel eluting with dichloromethane containing 2% methanol then trituration with diethyl ether gave 2-[3-(4-fluoro-3-(pyridazin-3-yl)phenyl)imidazo[1,2-α]pyrimidin-7-yl]propan-2-ol as a white solid: δH (400 MHz, CDCl3) 1.62 (6H, s), 4.46 (1H, s), 7.09 (1H, d, J 7), 7.41 (1H, dd, J 11 and 9), 7.61 (1H, dd, J 9 and 5), 7.64-7.68 (1H, m), 7.90 (1H, s), 8.07 (1H, dt, J 9 and 2), 8.43 (1H, dd, J 7 and 2), 8.72 (1H, d, J 7), 9.22 (1H, dd, J 5 and 2); m/z (ES+) 350 (M++H).

Workup

  1. customPurification by chromatography on silica gel eluting with dichloromethane containing 2% methanol

Sources & evidence

ORD record
ord-0460c3f6475443309b3e7e1d9ef6de84
Source dataset
uspto-grants-2005_05
Patent number
US06900215B2

Reaction notes

Loading…